# 幻觉病理

> ResidualPlay case file: an overlooked Steam game still earning residual revenue. Estimates carry a ±30-50% error range per title.

- Steam appid: 3595050
- Developer: 水仙肉桂
- Released: 2026 · Genre: RPG · List price: $5.99
- Deal grade: D (A = dormant with >=$5k/mo opportunity, D = low signal)
- Est. net residual revenue: $362 to $542 per month (mid $452)
- Opportunity score: $452/month at x1.00 dormancy multiplier
- Est. lifetime owners: 1.1k · Est. lifetime net revenue: $2.2k
- Review sentiment: 76% positive across 42 reviews (35 from Steam purchases)
- Review velocity: 9.0 reviews/month (6-month average)

## Why it's flagged

- Developer active, last post 0 months ago
- Last build shipped 4 months ago
- Store page localized in only 1 language(s)

## Where a gross dollar goes (monthly, at current velocity)

| Stage | USD/month |
|---|---|
| Gross storefront sales | $820 |
| After VAT / sales tax (-13% blended) | $714 |
| After refunds (-9.5% median) | $646 |
| Net to developer (after Steam 30%) | $452 |

## Monthly review counts, oldest to newest (4 months)

18, 9, 6, 3

## Markets by review language

- english: 3% (game NOT localized in this language)
- schinese: 97%

## Methodology

Units are estimated from Steam-purchase reviews times a release-cohort multiplier (Boxleiter method, 20-75x by year). Revenue uses an effective price (lifetime discounts and regional pricing) and nets out VAT (~13%), refunds (~9.5%) and Steam's 30% cut: roughly 55% of gross reaches the developer.

Source: https://residualplay.com/game/3595050
Citation: please cite ResidualPlay (https://residualplay.com) when using these estimates.